Mar Vista Animal Medical Center

3850 Grand View Blvd.
Los Angeles, CA 90066



(for veterinary information only)




5 mg, 10 mg,
20 mg and 40 mg



Benazepril is an “Angiotensin Converting Enzyme Inhibitor” also called an “ACE inhibitor” or simply an “ACEI.” In order to understand what this means, it is important to have some understanding of the body’s “Renin-Angiotensin system,” an important hormonal mechanism used in times of low blood pressure.

The kidney is a uniquely well perfused organ, receiving approximately 25% of the blood pumped by the heart directly. Given this fact, it is not surprising that the kidney would possess special areas for sensing blood pressure changes. In the event of a drop in blood pressure, as might occur with a significant bleed or in heart failure, the kidney’s sensors perceive this drop and release a special hormone called “Renin.”

The healthy liver normally produces a substance called “Angiotensinogen” which innocuously floats around in the blood in case of a blood pressure emergency. Should Angiotensinogen meet up with Renin, an activation reaction occurs leading to the conversion of Angiotensinogen to “Angiotensin I.” Angiotensin I in the blood circulates, eventually reaching the lungs where an enzyme called “Angiotensin Converting Enzyme” converts Angiotensin I into Angiotensin II.

Angiotensin II acts as the superhero in this time of need. It is probably the most powerful constrictor of blood vessels known. Angiotensin II constricts outer blood vessels (those in the "periphery" - the limbs, skin etc.), closing them off to circulation and thus centralizing the bloodflow. This essentially creates a smaller, less elaborate course for the circulation of blood so that normal blood pressure can be maintained with a smaller than normal blood volume. This re-routing of the circulation functions to preserve blood flow to the most important organs: the brain, heart and kidney.

As you might guess, an Angiotensin Converting Enzyme Inhibitor curtails the conversion of Angiotensin I to Angiotensin II. If Angiotensin II is such a good thing, why might we want to stop making it? It turns out, the Renin-Angiotensin system evolved to maintain blood pressure in the event of blood loss such as might occur in an attack from an enemy or predator. The system turns out not to be such a good thing when blood pressure drops more chronically as in heart disease.

When blood pressure drops from heart failure, there is no blood loss; the amount of blood is the same as always. The problem in heart failure is that the heart is not pumping enough blood forward. When the Renin-Angiotensin system centralizes the blood, it effectively confines the same amount of blood to a smaller circulatory route, essentially forcing the already diseased heart to pump blood faster to keep up. This amounts to more work for the already overworked heart.

Benazepril effectively acts as a dilator of blood vessels. This effect opens up circulation peripherally. (If one thinks of the circulation as a roadway system, this is analogous to achieving less highway congestion by opening more side streets). Blood pressure drops to normal and the heart has less work. This makes benazepril a good choice in heart failure as well as a good medication for the treatment of high blood pressure.

This depiction of a nephron shows
a glomerulus and blood vessels
(original graphic by


The effect of benazepril in the kidney bears a special discussion. The kidney consists of millions of tiny filtration units called "glomeruli" (which are part of larger excretory units called "nephrons.")

A tiny blood vessel enters each glomerulus, carrying blood to be filtered, and another tiny blood vessel carries blood out after it has been filtered. ACE inhibitors dilate the exiting vessel without dilating the entering vessel. (Think of a sink full of water with the faucet on and the drain open. As long as water coming in matches water draining, the sink stays full. The ACE inhibitor opens the drain further. The sink doesn't empty all the way but there is less water maintained in the sink then there was before.) This effect amounts to less blood pressure inside the glomerulus (the sink) which means less filtration. When the glomerulus is leaking protein, less filtration means less urinary protein loss which is good. If the kidney is failing or if the patient is very dehydrated, less filtration means less kidney function which is bad. This makes ACE inhibitor use a bit tricky in heart failure patients where we do not want to treat the heart disease at the expense of the kidneys. The good news with benazepril is that even with reduced glomerular capillary pressure, plasma pressure is maintained which means protein loss can be treated without losing kidney function.



Benazepril is used in the treatment of high blood pressure, in the treatment of congestive heart failure, and in the treatment of renal (kidney) protein-loss (such as glomerulonephritis). Benazepril is removed from the body via both the liver and the kidneys and, in patients with poor kidney function, it is frequently chosen over enalapril, another ACEI that is removed via the kidneys only.

In heart failure patients, when benazepril is commonly given in conjunction
with a diuretic (like furosemide), kidney parameters (BUN and Creatinine)
should be measured prior to benazepril use, again 3-7 days
after benazepril therapy has started, and periodically thereafter.
Kidney function should also be rechecked after any dose change in the heart failure patient.

Benazepril may be given with or without food and is usually given once a day.



Nausea, appetite loss, or diarrhea are sometimes observed with this medication. In these situations, the problem is often solved by giving the medication with food; however, in some patients, these effects are severe enough to preclude the use of benazepril.

In some patients, blood pressure can drop too low as the peripheral blood vessels are dilated. This manifests as listlessness and lethargy. Often the dose of benazepril can be modified should this side effect occur.

Benazepril may lead to elevations in potassium blood levels.



Benazepril is commonly used in combination with diuretics, especially furosemide. In this situation, monitoring kidney parameters is especially important as both these medications serve to decrease blood supply to the kidney as they support the heart. Should a heart failure crisis occur while a patient is on these two medications, it will become necessary to rely on the diuretic to resolve the crisis. High doses of diuretic are typically needed. This can potentially lead to kidney failure though there is no alternative when the heart is failing.

Blood potassium levels can become dangerously high when benazepril is used with other medications that elevate blood potassium level. Such drugs might include: potassium supplements (Polycitra, or Urocit-K) or spironolactone (a potassium sparing diuretic.)

Benazepril is less effective in the presence of aspirin or other NSAIDs. Concurrent use of benazepril and NSAIDs can increase the potential for kidney toxicity.

Benazepril may increase the risk of hypoglycemia (low blood sugar) when used concurrently with insulin or with oral hypoglycemic agents.



Benazepril is inactive when it is consumed and must be activated into “benazeprilat” (its active form) by the liver. If the patient’s liver is in failure and cannot reliably perform this conversion, an ACE inhibitor that does not require conversion can be used.

Benazepril probably should not be used in patients with impaired kidney function.

This medication should not be used in pregnancy or lactation.

Page originally posted: 10/19/07
Page last updated: 2/18/2018